Figure 2From: HMG-CoA reductase expression in primary colorectal cancer correlates with favourable clinicopathological characteristics and an improved clinical outcomeKaplan-Meier estimates of the prognostic impact of HMG-CoA reductase expression. Kaplan Meier analysis and log rank test of colorectal cancer specific survival according to negative, weak and strong HMGCR expression in (A) all patients, (B) patients with stage I-II disease and (C) patients with stage III-IV disease.Back to article page